Source: Annual Congress 2002 - Pleural disease
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
B. Romero Romero, K. Psathakis, E. Calderón Osuna, J. Martin Juan, J. Castillo Gómez, F. Rodrguez-Panadero (Seville, Spain). The profile of neutrophils and D-dimer in pleural fluid is useful to monitor the pleurodesis process after talc poudrage in malignant pleural effusions (MPE). Eur Respir J 2002; 20: Suppl. 38, 540

Member's Comments

No comment yet.

Related content which might interest you: Talc pleurodesis in malignant pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 386s Year: 2001 Efficacy of talc pleurodesis in patients with malignant pleural effusions Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011 Thoracoscopic talc pleurodesis in malignant pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 172s Year: 2005 Thoracoscopic talc pleurodesis in malignant pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 72s Year: 2005 Can serum (CRP) levels estimate the outome of talc pleurodesis in malignant pleural effusions? Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012 Efficacy of rapid pleurodesis in malignat pleural effusions Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010 Malignant pleural effusions Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=177 Year: 2002 CD8+ lymphocyte subpopulations in pleural fluid are associated with longer survival in patients with malignant pleural effusion (MPE) submitted to thoracoscopic talc pleurodesis Source: Eur Respir J 2002; 20: Suppl. 38, 70s Year: 2002 Efficacy and safety of talc pleurodesis in patients with malignant pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 754s Year: 2006 The value of thoracoscopy in malignant pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 516s Year: 2001 Talc mediates angiostasis in malignant pleural effusions via endostatin induction Source: Eur Respir J 2007; 29: 761-769 Year: 2007 The value of biochemical parameters of the pleural aspirate in predicting success of chemical pleurodesis in malignant pleural effusion Source: Annual Congress 2010 - Oncological problems, surgical risk and complications Year: 2010 Thoracoscopic talc pleurodesis‘(TTP) safety and clinical efficacy in malignant pleural effusions (MPE) Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010 Talc pleurodesis in malignant pleural effusions: A 5-year experience Source: Annual Congress 2012 - Medical access to the pleura Year: 2012 Comparison in effectiveness and proinflammatory mediators between talc, doxycycline and tetracycline for pleurodesis in malignant pleural effusions (MPE) Source: Annual Congress 2006 - New developments in diagnostic and therapeutic bronchoscopy and thoracoscopy Year: 2006 Day case rapid pleurodesis in malignant pleural effusion Source: Virtual Congress 2021 – Novelties in interventional pulmonology Year: 2021 Optimal treatment of pleurodesis for malignant pleural effusion in 2017 Source: ERS Skills course - Medical thoracoscopy Year: 2017 Efficacy of thoracoscopic talc poudrage pleurodesis and predictive factors for its success in malignant pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 72s Year: 2005 Thoracoscopic talc poudrage induces T-lymphopenia Source: Annual Congress 2005 - What's new in the pleura Year: 2005 Predictors of successful pleurodesis for patients with malignant pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 493s Year: 2004